trial

VR-based Avatar Therapy for Treatment of Auditory Hallucinations

NCTId NCT06505564
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 90 (estimated)
Sponsored by Semmelweis University
Primary completion 2025-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
90 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-03-01
Primary completion
2025-12-31
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Avatar therapy

Sponsors

Semmelweis UniversityLead Sponsor
University of BarcelonaCollaborator
Parc Sanitari Sant Joan de DéuCollaborator
Fundació Sant Joan de DéuCollaborator
Uniwersytet Medyczny w ŁodziCollaborator

Sites

4 total
Budapest, HungaryLodz, PolandBarcelona, SpainBarcelona, Spain

Facts & assertions

4 sourced
Enrollment
90
Phase
NA
Primary Completion Date
2025-12-31
Status
RECRUITING
relationships
The graph out of here
drug
Avatar therapy
drug
lead_sponsor
Semmelweis University
company
collaborator
University of Barcelona
company
Parc Sanitari Sant Joan de Déu
company
indication
Hallucinations
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication